tptx | Bristol Myers Squibb - Bristol Myers Squibb to Acquire Turning

Keyword	CPC	PCC	Volume	Score	Length of keyword
tptx	1.54	0.7	8004	33	4

Keyword	CPC	PCC	Volume	Score
tptx1	1.75	0.7	7484	45
tptx stock	0.2	0.2	6979	38
tptxwmc	1.36	1	1927	50
tptx model	0.47	0.4	102	95
tptx+	0.32	0.2	899	80
patxi	1.85	0.2	7828	80
tptxt	0.59	0.2	7132	47
tptx stock price	0.97	1	852	30
totx173	1.64	0.1	2433	36
tpt-1	0.73	0.6	6562	2
totx1350	1.37	0.9	6765	56
totx111	1.94	0.6	9369	84
totx177	1.09	0.3	7610	87
totx1952a f	1.57	0.2	4419	22
totx176	0.67	0.4	7065	91
tpt1042	0.03	0.4	6763	15
tpt1051v	0.85	0.4	835	82
tpt1145	1.78	1	1096	27
tpt1043q	1.77	0.5	5925	9
tpt1042vq-so1r-s	0.12	0.5	3453	97

Search Results related to tptx on Search Engine

Bristol Myers Squibb - Bristol Myers Squibb to Acquire Turning …
bms.com

https://news.bms.com/news/details/2022/Bristol-Myers-Squibb-to-Acquire-Turning-Point-Therapeutics-a-Leading-Precision-Oncology-Company/default.aspx

WEBJun 3, 2022 · NEW YORK & SAN DIEGO--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) today announced a definitive merger agreement under which Bristol Myers Squibb will acquire Turning Point Therapeutics for $76.00 per share. The transaction was unanimously approved by both …

DA: 80 PA: 6 MOZ Rank: 28

TPTX - Turning Point Therapeutics Stock Price - Barchart.com
barchart.com

https://www.barchart.com/stocks/quotes/TPTX

WEBTurning Point Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

DA: 49 PA: 68 MOZ Rank: 60

Turning Point Therapeutics (NASDAQ: TPTX) - The Motley Fool
fool.com

https://www.fool.com/quote/nasdaq/tptx/

WEBReal time Turning Point Therapeutics (TPTX) stock price quote, stock graph, news & analysis.

DA: 68 PA: 23 MOZ Rank: 37

TPTX Stock Doubles On Bristol Myers' $4.1 Billion All-Cash …
investors.com

https://www.investors.com/news/technology/tptx-stock-doubles-on-bristol-myers-all-cash-takeover/

WEBJun 3, 2022 · Licensing. ALLISON GATLIN. 04:14 PM ET 06/03/2022. Turning Point Therapeutics ( TPTX) snagged a $4.1 billion offer from Bristol Myers Squibb ( BMY) on Friday, and TPTX stock more than doubled....

DA: 51 PA: 42 MOZ Rank: 9

Turning Point Therapeutics Inc. (TPTX) Stock Price, News
thestreet.com

https://www.thestreet.com/quote/TPTX

WEBJun 3, 2022 · Get the latest Turning Point Therapeutics Inc. (TPTX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.

DA: 53 PA: 97 MOZ Rank: 63

Bristol Myers Squibb To Acquire Turning Point Therapeutics
nasdaq.com

https://www.nasdaq.com/articles/bristol-myers-squibb-to-acquire-turning-point-therapeutics-quick-facts

WEBPublished. Jun 3, 2022 09:14AM EDT. (RTTNews) - Bristol Myers Squibb (BMY) and Turning Point Therapeutics, Inc. (TPTX) announced a merger deal, under which Bristol Myers Squibb will acquire...

DA: 1 PA: 53 MOZ Rank: 89

TPTX Stock Soars 115% as Bristol-Myers Announces ... - InvestorPlace
investorplace.com

https://investorplace.com/2022/06/tptx-stock-soars-115-as-bristol-myers-announces-takeover-of-turning-point-therapeutics/

WEBJun 3, 2022 · Turning Point Therapeutics (NASDAQ: TPTX) is rising on acquisition news. Bristol-Myers Squibb (NYSE: BMY) is buying the company for $76 per share. TPTX’s repotrectinib is a major factor in...

DA: 8 PA: 86 MOZ Rank: 52

Turning Point Therapeutics, Inc. Common Stock (TPTX) - Nasdaq
nasdaq.com

https://www.nasdaq.com/market-activity/stocks/tptx/real-time

WEBTurning Point Therapeutics, Inc. Common Stock (TPTX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

DA: 1 PA: 39 MOZ Rank: 2

Turning Point Therapeutics Granted FDA Breakthrough Therapy
globenewswire.com

https://www.globenewswire.com/news-release/2020/12/08/2141343/0/en/Turning-Point-Therapeutics-Granted-FDA-Breakthrough-Therapy-Designation-for-Repotrectinib-Treatment-in-Patients-with-ROS1-Positive-Metastatic-Non-Small-Cell-Lung-Cancer-Who-Have-No.html

WEBSAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of...

DA: 44 PA: 2 MOZ Rank: 26

TPTX - Stock Quotes for Turning Point Therapeutics - Webull
webull.com

https://www.webull.com/quote/nasdaq-tptx

WEBWebull offers Turning Point Therapeutics stock information, including NASDAQ: TPTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TPTX stock news, and many more online …

DA: 30 PA: 2 MOZ Rank: 42